Hangzhou Fortune Gas Cryogenic Group Co Ltd
SSE:603173
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hangzhou Fortune Gas Cryogenic Group Co Ltd
SSE:603173
|
CN |
|
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
UK |
|
A
|
ALD SA
PAR:ALD
|
FR |
|
Nitco Ltd
NSE:NITCO
|
IN |
|
GTN Industries Ltd
BSE:500170
|
IN |
|
Agesa Hayat ve Emeklilik AS
IST:AGESA.E
|
TR |
|
A
|
Allane SE
XETRA:LNSX
|
DE |
|
X
|
Ximei Resources Holding Ltd
HKEX:9936
|
CN |
|
P
|
Pfizer Inc
SWB:PFE
|
US |
|
A
|
AHT Syngas Technology NV
F:3SQ1
|
DE |
|
E
|
EDU Holdings Ltd
ASX:EDU
|
AU |
|
C
|
CIMC Enric Holdings Ltd
HKEX:3899
|
CN |
|
B
|
Banco Santander Brasil SA
BOVESPA:SANB3
|
BR |
Wall Street
Price Targets
Price Targets Summary
Hangzhou Fortune Gas Cryogenic Group Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hangzhou Fortune Gas Cryogenic Group Co Ltd's stock price target?
Not Available
Hangzhou Fortune Gas Cryogenic Group Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hangzhou Fortune Gas Cryogenic Group Co Ltd's Revenue forecast?
Projected CAGR
27%
For the last 3 years the compound annual growth rate for Hangzhou Fortune Gas Cryogenic Group Co Ltd's revenue is 19%. The projected CAGR for the next 2 years is 27%.
What is Hangzhou Fortune Gas Cryogenic Group Co Ltd's Net Income forecast?
Projected CAGR
38%
For the last 3 years the compound annual growth rate for Hangzhou Fortune Gas Cryogenic Group Co Ltd's net income is 18%. The projected CAGR for the next 2 years is 38%.
